Skip to content
10-Q

Quarterly Report

Poseida Therapeutics, Inc.

0000950170-24-123331

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 1, 2024 97.47M sh
Shares Diluted Q3 2024 · Sep 30, 2024 98.22M sh
Shares Diluted Q3 2024 · Sep 30, 2024 96.72M sh
Shares Diluted Q3 2024 · Sep 30, 2023 91.9M sh
Shares Diluted Q3 2024 · Sep 30, 2023 88.32M sh
Capex Q3 2024 · Sep 30, 2024 $1.79M
Capex Q3 2024 · Sep 30, 2023 $2.76M
Operating Cash Flow Q3 2024 · Sep 30, 2024 $13.72M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$63.42M
Long Term Debt Q3 2024 · Sep 30, 2024 $58.91M
Long Term Debt Q3 2024 · Dec 31, 2023 $58.59M
Short Term Investments Q3 2024 · Sep 30, 2024 $181.51M
Short Term Investments Q3 2024 · Dec 31, 2023 $167.73M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $49.34M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $44.47M
Stockholders Equity Q3 2024 · Sep 30, 2024 $87.21M
Stockholders Equity Q3 2024 · Jun 30, 2024 $60.82M
Stockholders Equity Q3 2024 · Mar 31, 2024 $84.59M
Stockholders Equity Q3 2024 · Dec 31, 2023 $103.7M
Stockholders Equity Q3 2024 · Sep 30, 2023 $123.66M
Stockholders Equity Q3 2024 · Jun 30, 2023 $135.3M
Stockholders Equity Q3 2024 · Mar 31, 2023 $157.57M
Stockholders Equity Q3 2024 · Dec 31, 2022 $187.6M
Current Liabilities Q3 2024 · Sep 30, 2024 $78.27M
Current Liabilities Q3 2024 · Dec 31, 2023 $71.32M
Total Liabilities Q3 2024 · Sep 30, 2024 $206.37M
Total Liabilities Q3 2024 · Dec 31, 2023 $170.18M
Current Assets Q3 2024 · Sep 30, 2024 $250.7M
Current Assets Q3 2024 · Dec 31, 2023 $226.48M
Total Assets Q3 2024 · Sep 30, 2024 $293.58M
Total Assets Q3 2024 · Dec 31, 2023 $273.89M
Eps Diluted Q3 2024 · Sep 30, 2024 $0.21
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.37
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.35
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.11
Eps Basic Q3 2024 · Sep 30, 2024 $0.21
Eps Basic Q3 2024 · Sep 30, 2024 −$0.37
Eps Basic Q3 2024 · Sep 30, 2023 −$0.35
Eps Basic Q3 2024 · Sep 30, 2023 −$1.11
Sga Expense Q3 2024 · Sep 30, 2024 $10.09M
Sga Expense Q3 2024 · Sep 30, 2024 $32.07M
Sga Expense Q3 2024 · Sep 30, 2023 $8.09M
Sga Expense Q3 2024 · Sep 30, 2023 $28.58M
Rd Expense Q3 2024 · Sep 30, 2024 $41.91M
Rd Expense Q3 2024 · Sep 30, 2024 $130.38M
Rd Expense Q3 2024 · Sep 30, 2023 $37.48M
Rd Expense Q3 2024 · Sep 30, 2023 $114.73M
Net Income Q3 2024 · Sep 30, 2024 $20.24M
Net Income Q3 2024 · Sep 30, 2024 −$35.41M
Net Income Q3 2024 · Jun 30, 2024 −$31.37M
Net Income Q3 2024 · Mar 31, 2024 −$24.27M
Net Income Q3 2024 · Sep 30, 2023 −$31.78M
Net Income Q3 2024 · Sep 30, 2023 −$98.08M
Net Income Q3 2024 · Jun 30, 2023 −$27.46M
Net Income Q3 2024 · Mar 31, 2023 −$38.85M
Operating Income Q3 2024 · Sep 30, 2024 $19.74M
Operating Income Q3 2024 · Sep 30, 2024 −$36.59M
Operating Income Q3 2024 · Sep 30, 2023 −$36.22M
Operating Income Q3 2024 · Sep 30, 2023 −$103.6M
Revenue Q3 2024 · Sep 30, 2024 $71.75M
Revenue Q3 2024 · Sep 30, 2024 $125.86M
Revenue Q3 2024 · Sep 30, 2023 $9.35M
Revenue Q3 2024 · Sep 30, 2023 $39.71M